Morningside Group Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 22
Professionals
  • Investments
  • 307
  • Portfolio
  • 143
  • Exits
  • 89
Exits

Morningside Group General Information

Description

Morningside Group is an investment firm that was founded in 1986 and is based in Hong Kong, Hong Kong. The firm makes private equity and venture capital investments in the information technology, life sciences and clean technology sectors. It also participates in philanthropic activities to enable education, support science and fund medical research.

Contact Information

Year Founded
1986
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
PE/Buyout
Primary Office
  • 22nd Floor, Hang Lung Centre
  • 2-20 Paterson Street, Causeway Bay30
  • Hong Kong
  • Hong Kong

Morningside Group Investments (307)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Almond (Financial Software) 27-Dec-2021 Seed Round 000 Financial Software Generating Revenue 0000 00000
0000 0000000 00000 23-Nov-2021 00000 00000 000.00 Application Software Generating Revenue 0000000 00000
00000000 000000000 18-Nov-2021 00000 00000 00000 Discovery Tools (Healthcare) Generating Revenue
0000000000 16-Nov-2021 00000 00000 00000 Diagnostic Equipment Generating Revenue 00000 000000 00.0
00000000 08-Nov-2021 00000 00000 0000 Drug Discovery Generating Revenue 0000000 00000
000000 05-Nov-2021 0000 00000 00.000 Agricultural Chemicals Startup
00000000 000000000 03-Nov-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3 00000 000000 00.0
00000000 (000 0000 03-Nov-2021 00000 00000 0000 Other Healthcare Technology Systems Generating Revenue 0000000 00000
BetterUp 08-Oct-2021 Later Stage VC 00000 Educational Software Generating Revenue
Exo Therapeutics 05-Oct-2021 Early Stage VC 000.00 Drug Discovery Generating Revenue
You’re viewing 10 of 307 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Morningside Group Exits (89)

Company Name Exit Date Exit Type Exit Size
Amylyx 07-Jan-2022 IPO 00000
00000000 28-Sep-2021 0000000 000000
00000 000000000 00 01-Sep-2021 000000000 00000000
00000000 000000 16-Jul-2021 000 00000
00000000 000000000 31-Mar-2021 0000000000: 000000
000000 24-Feb-2021 000000000000000000
0000 0000000000000 05-Feb-2021 000000000000000000
0000000 08-Jan-2021 000 00000
Forensic Logic 01-Jan-2021 Secondary Transaction - Private
Atea Pharmaceuticals 30-Oct-2020 IPO 00000
You’re viewing 10 of 89 exits. Get the full list »

Morningside Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Morningside Group Team (32)

Name Title Deals Funds Boards Office
Ka Chang Managing Director 0 0 Hong Kong, Hong Kong
Lu Huang MD Managing Director, Asia Venture 0 0 Shanghai, China
Qin Liu Co-Founder, Investment Director & Board Member 0 0 0 Shanghai, China
Stephen Bruso Executive 0 0 Hong Kong, Hong Kong
Lili Shen Healthcare Investment 0 0 Hong Kong, Hong Kong
You’re viewing 5 of 32 team members. Get the full list »

Morningside Group Co-Investors (344)

Name With Exits Lead Partner Series Industry
General Catalyst 3 0 Series chart Industry bar
Andera Partners 0 0 Series chart Industry bar
Bessemer Venture Partners 0 0 Series chart Industry bar
Forbion 0 0 Series chart Industry bar
T. Rowe Price 0 0 Series chart Industry bar
You’re viewing 5 of 344 co-investors. Get the full list »